Tioga Research joined fellow San Diego companies, Nucleus Biologics and Scientist, and CONNECT, UCSD and NF Corporation as contributors with the Biocom booth at the annual BioJapan meeting in Yokohama, October 11-13. The Japan counterpart to the global Bio meeting in the US, BioJapan is Asia’s premier partnering event for the global biotechnology industry. BioJapan 2017 hosted representatives from companies, institutions, development organizations and university groups from across Japan, Asia, North America and Europe and welcomed some 5,000 visitors on each of its three days. The San Diego delegation included Biocom CEO, Joe Panetta, CONNECT CEO, Greg McKee, San Diego City Council member Chris Cate, and Biocom Japan representative, Tony Fujita.
“The investment we made in participating in BioJapan 2017 certainly delivered handsomely”, noted Tioga Research CEO, John M Newsam. “Through access to the partnering system we had pre-arranged meetings with quite a number of groups, some that we had solicited and with others that had reached out to us. Some of these meetings do look set to lead to new business for us. As importantly, we had a succession of near-chance discussions at the Biocom booth, with an estimated 70% of such discussions leading to immediate follow up. One of my goals in attending had been to identify a local facilitator for our further business growth in Japan. As a result of meetings at BioJapan, we now have a shortlist of prospective facilitator candidates to develop further. To enable these various successful meetings, Tony Fujita did a super job, ensuring that organization, logistics (supported ably by the NF Corporate team which worked tirelessly at the event itself and in booth set-up and tear-down), and management of the various day-to-day activities were efficient and effective. For a participant like Tioga Research, the strong connections that Biocom has already built in Japan proved to be an additional asset.”
John M Newsam also participated in a Global Life Science Cluster Reception at the Link-J facilities in Nihonbashi, Tokyo prior to the start of BioJapan.